Scientists have found a “switch”, which develop inflammatory diseases

None of the processes in our body does not happen by itself. It is proved that for any reaction or response to any irritation meets a number of substances, which for simplicity are referred to as “switches”. Just recently a group of researchers from Trinity College (Dublin, Ireland) found a similar mechanism for inflammatory diseases.

Now about the immunity we know a little bit more

What is the inflammation?

First, let’s understand what exactly is inflammation and why is it necessary to our body. We should not think that the inflammation is always very bad. Because in fact it is a protective mechanism that allows us to adapt. Inflammation is a complex process that occurs in response to damage as of a mechanical nature, and by the action of pathogens like toxins or metabolic products of bacteria or viruses. Inflammation aims to eliminate “bad” foods, and, if possible, and agents of the damage.

However, in some conditions the inflammation just are not able to completely overcome what caused tissue damage. And then this protective mechanism would only create additional, that is to say, “difficulties” for the whole organism.

Returning to the current study. As reported on the website of Trinity College, scientists from a given institution found the main metabolic “switch” for inflammatory diseases. The research team identified that in this process the main role of a squirrel entitled “PKM2”. However, he participates as locally, in the development of inflammatory response, and in General regulates several types of immune cells. In particular, involved two types of cells — Th17 and Th1 cells, which are responsible for the development of autoimmune reactions.

Th17 and Th1 cells is very important for the occurrence of response that occurs in autoimmune diseases. For example, in diseases such as psoriasis or multiple sclerosis. We found that interference with the work of PKM2 inhibits Th17 and Th1 cells and limits inflammation. say leading the authors Dr. Stefano, Anghiari and Professor Luke O’neill. PKM2 is an amazing protein that plays an important role in how cells use glucose for energy, but he also “moonlights” in the immune system where we did not expect to see him and even more so to learn that it is for immunity and inflammation is extremely important.

Currently, experts are studying the possibility of creating therapeutic agents effect on protein РКМ2. In this case, the options may be few — or “tying” РКМ2 before it begins its work inside the body, either reducing its production by acting on cells of the immune system that are involved in its creation.

However, each approach can be negative consequences, because, as already mentioned, РКМ2 plays a role in glucose metabolism (which is the main energy component of our body that help to live). Therefore, to interfere in the work РКМ2 it in such a way so as not to upset the balance of the other systems of our body.